Completed
Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan
NCT00871494
- Conditions
- Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
- Locations
-
- Pfizer Investigational Site Aichi-gun, Aichi-ken, Japan
- Pfizer Investigational Site Ichinomiya, Aichi-ken, Japan
- Pfizer Investigational Site Nagoya-city Naka-ku, Aichi-ken, Japan
- Pfizer Investigational Site Tanba-gun Fusou-chou, Aichi-ken, Japan